Jesy Nelson has drawn attention to the glaring disparities in access to spinal muscular atrophy (SMA) treatments, emphasising how geography continues to dictate patient outcomes. Highlighting this “postcode lottery,” Nelson criticised the inconsistent availability of life-saving therapies, which leaves families in certain regions without timely support while others benefit from cutting-edge interventions. Her comments come as pressure mounts on policymakers ahead of a crucial parliamentary debate aimed at standardising healthcare provisions for rare diseases nationwide.

Recent data reveals stark contrasts in treatment rollout, with some areas reporting treatment initiation within weeks of diagnosis, while others face delays stretching into months or longer. Nelson called for a unified approach, urging the government to ensure:

  • Equitable funding allocation across NHS trusts
  • Improved patient referral pathways to specialised centres
  • Transparent reporting on SMA treatment availability and outcomes
Region Average Treatment Wait Time Treatment Centres
North West 2 weeks 3
South East 6 weeks 5
Midlands 3 months 2
Scotland 4 weeks 2
Wales 8 weeks 1